Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

More than 1 in 4 organizations spend between $100,000 and $500,000 in audit penalties annually, according to a joint study by ...